Correlation Between GlaxoSmithKline PLC and Schwab Intermediate

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Schwab Intermediate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Schwab Intermediate into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Schwab Intermediate Term Treasury, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Schwab Intermediate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Schwab Intermediate. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Schwab Intermediate.

Diversification Opportunities for GlaxoSmithKline PLC and Schwab Intermediate

0.83
  Correlation Coefficient

Very poor diversification

The 3 months correlation between GlaxoSmithKline and Schwab is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Schwab Intermediate Term Treas in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Schwab Intermediate and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Schwab Intermediate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Schwab Intermediate has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Schwab Intermediate go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Schwab Intermediate

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 1.1 times less return on investment than Schwab Intermediate. In addition to that, GlaxoSmithKline PLC is 3.51 times more volatile than Schwab Intermediate Term Treasury. It trades about 0.01 of its total potential returns per unit of risk. Schwab Intermediate Term Treasury is currently generating about 0.05 per unit of volatility. If you would invest  2,248  in Schwab Intermediate Term Treasury on August 24, 2024 and sell it today you would earn a total of  195.00  from holding Schwab Intermediate Term Treasury or generate 8.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Schwab Intermediate Term Treas

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Schwab Intermediate 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Schwab Intermediate Term Treasury has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable technical indicators, Schwab Intermediate is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

GlaxoSmithKline PLC and Schwab Intermediate Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Schwab Intermediate

The main advantage of trading using opposite GlaxoSmithKline PLC and Schwab Intermediate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Schwab Intermediate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Schwab Intermediate will offset losses from the drop in Schwab Intermediate's long position.
The idea behind GlaxoSmithKline PLC ADR and Schwab Intermediate Term Treasury pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios